Zepp Health Corporation each representing sixteen (Class A) (ZEPP) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$2.25 -3.85% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

Zepp Health Corporation each representing sixteen (Class A) (ZEPP) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $33.0M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
RQD QUANT TACHOMETERRED ALERT • D-
025507510035
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D+
Cash (3)Whales (7)SEC (8)Macro (13)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-10.2% Base Target
$44 Bull$2 Base$2 Bear
📬 FREE ZEPP RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ZEPP)Realized 20D OHLCV Swing Band: ±12.5%
SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

ZEPP Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →
▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (ZEPP)

No recent open-market Form 4 cluster sales or emergency dumps flagged on ZEPP. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ZEPP)

  • ✓Walkthrough of ZEPP's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ZEPP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -87.12%🛡️ HOLDING TREND SUPPORT
2026-10-30O $2.16H $2.25L $2.15C $2.25VOL 112.6K
RES: $6.64SUP: $1.76SMA50: $3.96SMA200: $10.17
$30.53$22.84$15.14$7.45$-0.24RES $6.64SUP $1.76$2.252026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ZEPP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +41.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ZEPP today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ZEPP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ZEPP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ZEPP)

Technology Rank #624 of 714 ⚔️ OSS vs ZEPP Full Matrix →

1. Head-to-Head Technology Peer Comparison (ZEPP vs. OSS, SCKT, XNDU, OMCL)

Industry: Computer Manufacturing (9 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, Zepp Health Corporation each representing sixteen (Class A) (ZEPP) ranks #624 by composite RQD confidence (35/100, grade D-) and #584 by equity capitalization ($33.0M). Within this direct 5-issuer industry benchmark cohort, OSS leads on earnings valuation at 28.6x trailing P/E, while OMCL leads on capital efficiency and profitability with 0.4% ROIC and 42.5% gross margin. OMCL currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with ZEPP at 35/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
ZEPP ACTIVE
Zepp Health Corporation each representing sixteen (Class A)
D- 35/100 — 38.3% -14.7% -3.85% $33.0M Benchmark Subject
OSS
One Stop Systems Inc.
D 47/100 28.6x 49.6% -18.0% -6.88% $145.7M /oss-vs-zepp →
SCKT
Socket Mobile Inc.
D- 40/100 — 49.7% -35.0% +5.94% $3.0M /sckt-vs-zepp →
XNDU
Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares
D 49/100 — — — -3.11% $946.1M /xndu-vs-zepp →
OMCL
Omnicell Inc. ($0.001 par value)
C- 61/100 — 42.5% 0.4% +2.59% $1.68B /omcl-vs-zepp →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001720446

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Zepp Health Corporation each representing sixteen (Class A) (ZEPP) reported GAAP revenue of $258.9M (+41.8% vs. FY2024 revenue of $182.6M , and -26.6% cumulative change since FY2023) , GAAP net income of -$40.1M, operating cash flow of -$25.7M, and free cash flow of -$26.2M (-1.6% YoY). On the balance sheet, ZEPP closed FY2025 with $564.8M in total assets against $0 in total debt (Altman Z-Score: 0.33, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $258.9M -$40.1M -$25.7M -$26.2M $564.8M —
FY2024 (FY) 2024-12-31 $182.6M -$75.7M -$24.4M -$25.8M $528.6M —
FY2023 (FY) 2023-12-31 $352.9M -$31.0M $42.6M $42.6M — —

3. ZEPP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ZEPP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Zepp Health Corporation each representing sixteen (Class A) (NYSE: ZEPP) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.25 (-3.85% 1D, market cap $33.0M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 5/20. Across 714 tracked Technology issuers, ZEPP ranks #624 in composite RQD confidence.

How does ZEPP compare to OSS and SCKT in the Technology sector?

Within the Technology sector (Computer Manufacturing), ZEPP carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 38.3%, and ROIC of -14.7%. By comparison, OSS (One Stop Systems Inc.) holds a D grade (47/100 RQD, P/E 28.6x, ROIC -18.0%, cap $145.7M) and SCKT (Socket Mobile Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $3.0M). Among the 5-stock peer group, OSS leads on earnings multiple (28.6x) while OMCL leads on capital efficiency (0.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ZEPP?

Per ZEPP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001720446), Zepp Health Corporation each representing sixteen (Class A) generated $258.9M in revenue (+41.8% YoY), -$40.1M in net income, and -$26.2M in free cash flow against $564.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ZEPP trading relative to its 50-day, 200-day, and 52-week technical levels?

ZEPP last traded at $2.25 (-3.85% on volume of 68,747 shares), positioning the stock -43.18% below its 50-day simple moving average ($3.96) and -77.88% below its 200-day simple moving average ($10.17). Across its 52-week range of $2.15 to $42.35, ZEPP sits at the 0.2% percentile with a 14-day RSI of 11.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.97 to $2.53).

ZEPP Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are ZEPP insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies ZEPP leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%